Investigational Drug Program
The Investigational Drug Program (IDP) at the BC Cancer Agency offers fee-for-service preclinical research and contract manufacturing services to both academic and private sector researchers. With a focus on cancer therapeutics, IDP collaborates closely with its partners to advance promising therapeutic compounds to the stage of early-phase human clinical trials.
Equipped with fully compliant GLP and GMP facilities, IDP has successfully produced over 130 distinct batches of injectable experimental drug formulations. The program's highly skilled team provides comprehensive management of in vitro and in vivo research services, ensuring timely and cost-effective guidance for product development through established relationships with oncology specialists.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.